All In Biotech

Drug Trial Radar · NCT07155668

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

A Randomized, Open-label Study Evaluating the Safety, Tolerability and Pharmacokinetics of VRDN-003 Administered Subcutaneously in Participants With Thyroid Eye Disease (TED)

Last checked: Nov 20, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

87

Actual

Start

Jul 1, 2025

Primary completion

May 28, 2026

Study completion May 28, 2026

Sponsor

Lead sponsor
Viridian Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 4, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a clinical trial assessing the safety, tolerability and pharmacokinetics (PK) of an investigational drug, VRDN-003, in participants with TED (Thyroid Eye Disease)

Conditions

  • Thyroid Eye Disease

Interventions

  • VRDN-003Drug

    VRDN-003 is an investigational, subcutaneously administered, humanized monoclonal antibody directed against the Insulin-like Growth Factor-1 receptor (IGF-1R).

  • AutoinjectorDevice

    The autoinjector is a single-dose, disposable, ready-to-use delivery device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment Emergent Adverse Event (TEAE) incidence rateTime frame: Through Week 24

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • United Medical Research Institute

    Inglewood, California

  • C&A Clinical Trials Corp

    Cape Coral, Florida

  • Ilumina Medical Research

    Kissimmee, Florida

  • Med-Care Research

    Miami, Florida

  • Continental Clinical Research, llc

    Miami, Florida

  • Hype Clinical Research, LLC

    Miami, Florida

  • Advanced Quality Medical Research, LLC

    Orland Park, Illinois

  • Ophthalmic Consultants of Boston

    East Weymouth, Massachusetts

  • Fraser Eye Center

    Fraser, Michigan

  • Kahana Oculoplastic and Orbital Surgery

    Livonia, Michigan

  • Vector Clinical Trials

    Sparks, Nevada

  • Baylor College of Medicine, Alkek Eye Center

    Houston, Texas

  • Neuro Eye Clinical Trials INC

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.